«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

29卷

期数:

2023年06期

页码:

575-581

栏目:

肿瘤研究专题

出版日期:

2023-11-20

文章信息/Info

Title:

Effects of the combination of Erastin and BIBR1532 on the proliferation of gastric cancer cells

文章编号:

1006-8147(2023) 06-0575-07

作者:

杨秋慧; 郝名英; 刘思琪; 黄欣宇; 耿鑫

（天津医科大学基础医学院生物化学与分子生物学系，天津300070）

Author(s):

YANG Qiu-hui; HAO Ming-ying; LIU Si-qi; HUANG Xin-yu; GENG Xin

（Department of Biochemistry and Molecular Biology，School of Basic Medical Sciences，Tianjin Medical University，Tianjin 300070，China）

关键词:

GPX4; 胃癌; 铁死亡; 端粒酶

Keywords:

GPX4; gastric cancer; ferroptosis; telomerase

分类号:

R735.2

DOI:

-

文献标志码:

A

摘要:

目的：探究Erastin和BIBR1532（端粒酶抑制剂）联合应用对胃癌细胞增殖的影响。方法：使用TIMER2.0、GEPIA2.0数据库比较胃癌组织和相应的正常胃黏膜组织中谷胱甘肽过氧化物酶 （GPX4）基因的表达水平，并通过GEPIA2.0预测GPX4是否影响胃癌患者的生存和预后。利用STRING数据库构建GPX4蛋白相互作用网络。10、20 μmol/L Erastin干扰GPX4表达，通过Western印迹及TRAP（端粒酶活性测定）实验检测TERT蛋白表达量以及端粒酶活性的变化。应用CCK8增殖实验、克隆形成实验检测细胞活力。结果：TIMER2.0和GEPIA2.0数据库检索结果显示胃癌组织中的GPX4表达水平明显高于正常组织，高水平的GPX4与胃癌患者不良预后相关（P<0.05）。STRING蛋白相互作用网络分析显示，GPX4蛋白相互作用网络包括TERT、SLC7A11、PINX1、HSP90AA1、DKC1、SLC3A2、SMARCA4、PIF1、CTNNB1、WRAP53、SMG6、RUVBL1。10、20 μmol/L Erastin干扰GPX4蛋白表达后，TRAP实验结果显示细胞端粒酶活性明显降低（t=34.29、14.28，均P<0.001），Western印迹结果显示TERT蛋白表达量明显降低（t=3.599、8.144，均P<0.05）。CCK8和克隆形成实验结果显示细胞生长增殖能力降低（t=8.662、27.88，均P<0.001）。10 μmol/L Erastin与75 μmol/L BIBR1532联合使用导致胃癌细胞端粒酶活性和TERT蛋白表达量进一步降低（t=9.931、4.918，均P<0.01），导致细胞增殖能力降低更明显（t=4.157、25.46，均P<0.05）。结论：GPX4在胃癌组织中高表达，Erastin和BIBR1532联合使用在干扰GPX4表达的同时，细胞内端粒酶活性和TERT蛋白表达量进一步降低，抑制胃癌细胞增殖。

Abstract:

Objective： To explore the effects of the combination of Erastin and BIBR1532（telomerase inhibitor） on the proliferation of gastric cancer cells. Methods：Relevant data from TIMER2.0 and GEPIA2.0 databases regarding glutathione peroxidase（GPX4）gene expression level in gastric cancer samples and corresponding normal gastric mucosal samples were analyzed. GEPIA 2.0 was used to predict whether GPX4 affects the survival and prognosis of gastric cancer（GC） patients. The GPX4 protein interaction network was constructed using STRING database. GPX4 expression was interfered with 10，20 μmol/L Erastin，the changes of TERT protein expression and telomerase activity were detected by Western blotting and TRAP （telomerase activity assay） experiments. Cell viability was detected through CCK8 proliferation and clone formation experiments. Results：The results of TIMER2.0 and GEPIA2.0 databases showed that GPX4 expression level in GC tissues was significantly higher than that in normal tissues，and high GPX4 level was associated with poor prognosis in GC patients（P<0.05）. The analysis of STRING protein interaction network showed that GPX4 protein interaction network included TERT，SLC7A11，PINX1，HSP90AA1，DKC1，SLC3A2，SMARCA4，PIF1，CTNNB1，WRAP53，SMG6 and RUVBL1. The results of TRAP experiment showed that telomerase activity significantly decreased after GPX4 expression was interfered with 10，20 μmol/L Erastin（t=34.29，14.28，both P<0.001）. Western blotting results showed that TERT protein expression level was significantly decreased（t=3.599，8.144，both P<0.05）.The results of CCK8 and clone formation experiments showed a decrease in cell growth and proliferation （t=8.662，27.88，both P<0.001）.The combined treatment of 10 μmol/L Erastin and 75 μmol/L BIBR1532 reduced the telomerase activity and the expression of TERT protein in GC cells（t=9.931，4.918，both P<0.01），resulting in a more significant decrease in cell proliferation（t=4.157，25.46，both P<0.05）. Conclusion：GPX4 is highly expressed in GC tissues. The combination of Erastin and BIBR1532 further reduces intracellular telomerase activity and TERT protein expression after interfering with GPX4 expression，ultimately inhibiting the proliferation of GC cells.

参考文献/References:

[1] BRAY F，FERLAY J，SOERJOMATARAM I，et al. Global cancer statistics 2018：globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin，2018，68（6）：394-424.
[2] CHEN W，ZHENG R，BAADE P D，et al. Cancer statistics in China，2015[J]. CA Cancer J Clin，2016，66（2）：115-132.
[3] BOLLSCHWEILER E，BERLTH F，BALTIN C，et al. Treatment of early gastric cancer in the western world[J]. World J Gastroenterol，2014，20（19）：5672-5678.
[4] WANG Y，ZHANG L，YANG Y，et al. Progress of gastric cancer surgery in the era of precision medicine[J]. Int J Biol Sci，2021，17（4）：1041-1049.
[5] TANG D，CHEN X，KANG R，et al. Ferroptosis：molecular mechanisms and health implications[J]. Cell Res，2021，31（2）：107-125.
[6] CHEN X，KANG R，KROEMER G，et al. Broadening horizons：the role of ferroptosis in cancer[J]. Nat Rev Clin Oncol，2021，18（5）：280-296.
[7] TANG D，KROEMER G. Ferroptosis[J]. Curr Biol，2020，30（21）：R1292-R1297.
[8] FRIEDMANN ANGELI J P，CONRAD M. Selenium and GPX4，a vital symbiosis[J]. Free Radic Biol Med，2018，127：153-159.
[9] FORCINA G C，DIXON S J. GPX4 at the crossroads of lipid homeostasis and ferroptosis[J]. Proteomics，2019，19（18）：e1800311.
[10] IMAI H，MATSUOKA M，KUMAGAI T，et al. Lipid peroxidation-dependent cell death regulated by GPX4 and ferroptosis[J]. Curr Top Microbiol Immunol，2017，403：143-170.
[11] HANGAUER M J，VISWANATHAN V S，RYAN M J，et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition[J]. Nature，2017，551（7679）：247-250.
[12] ZHANG W，JIANG B，LIU Y，et al. Bufotalin induces ferroptosis in non-small cell lung cancer cells by facilitating the ubiquitination and degradation of GPX4[J]. Free Radic Biol Med，2022，180：75-84.
[13] CHEN L，ZHANG C，MA W，et al. METTL3-mediated m6A modification stabilizes TERRA and maintains telomere stability[J]. Nucleic Acids Res，2022，50（20）：11619-11634.
[14] YU Z，JIANG F，HU C，et al. Functionalized nanoprobes for in situ detection of telomerase[J]. Chem Commun（Camb），2021，57（31）：3736-3748.
[15] CHEN X，TANG W-J，SHI J B，et al. Therapeutic strategies for targeting telomerase in cancer[J]. Med Res Rev，2020，40（2）：532-585.
[16] LI T，FAN J，WANG B，et al. TIMER：a web server for comprehensive analysis of tumor-infiltrating immune cells[J]. Cancer Res，2017，77（21）：e108-e110.
[17] TANG Z，LI C，KANG B，et al. GEPIA：a web server for cancer and normal gene expression profiling and interactive analyses[J]. Nucleic Acids Res，2017，45（W1）：W98-W102.
[18] SMYTH E C，NILSSON M，GRABSCH H I，et al. Gastric cancer[J]. Lancet，2020，396（10251）：635-648.
[19] ARAI H，NAKAJIMA T E. Recent developments of systemic chemotherapy for gastric cancer[J]. Cancers（Basel），2020，12（5）：1100.
[20] WEI L，SUN J，ZHANG N，et al. Noncoding RNAs in gastric cancer：implications for drug resistance[J]. Mol Cancer，2020，19（1）：62.
[21] WANG Y，ZHENG L，SHANG W，et al. Wnt/beta-catenin signaling confers ferroptosis resistance by targeting GPX4 in gastric cancer[J]. Cell Death Differ，2022，29（11）：2190-2202.
[22] JIANG X，STOCKWELL B R，CONRAD M. Ferroptosis：mechanisms，biology and role in disease[J]. Nat Rev Mol Cell Biol，2021， 22（4）：266-282.
[23] FRIEDMANN ANGELI J P，SCHNEIDER M，PRONETH B，et al. Inactivation of the ferroptosis regulator GPX4 triggers acute renal failure in mice[J]. Nat Cell Bio，2014，16（12）：1180-1191.
[24] ZOU Y，PALTE M J，DEIK A A，et al. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis[J]. Nat Commun，2019，10（1）：1617.
[25] SU Y，ZHAO B，ZHOU L，et al. Ferroptosis，a novel pharmacological mechanism of anti-cancer drugs[J]. Cancer Lett，2020，483：127-136.
[26] DIXON S J，LEMBERG K M，LAMPRECHT M R，et al. Ferroptosis：an iron-dependent form of nonapoptotic cell death[J]. Cell，2012，149（5）：1060-1072.
[27] ZHANG H，DENG T，LIU R，et al. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer[J]. Mol Cancer，2020，19（1）：43.
[28] GUAN Z，CHEN J，LI X，et al. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation[J]. Biosci Rep，2020，40（8）：BSR20201807.
[29] LIANG C，ZHANG X，YANG M，et al. Recent progress in ferroptosis inducers for cancer therapy[J]. Adv Mater，2019，31（51）：e1904197.
[30] DEMANELIS K，JASMINE F，CHEN L S，et al. Determinants of telomere length across human tissues[J]. Science（New York，NY），2020，369（6509）：eaaz6876.
[31] LIN J，EPEL E. Stress and telomere shortening：Insights from cellular mechanisms[J]. Ageing Res Rev，2022，73：101507.
[32] J?魧GER K，MENSCH J，GRIMMIG M E，et al. A conserved long-distance telomeric silencing mechanism suppresses mTOR signaling in aging human fibroblasts[J]. Sci Adv，2022，8（33）：eabk2814.
[33] WANG Y，SU?譒AC L，FEIGON J. Structural biology of telomerase[J]. Cold Spring Harb Perspect Biol，2019，11（12）：a032383.
[34] DONG H，XIA Y，JIN S，et al. Nrf2 attenuates ferroptosis-mediated IIR-ALI by modulating TERT and SLC7A11[J]. Cell Death Dis，2021，12（11）：1027.
[35] LIU B，HE Y，WANG Y，et al. Structure of active human telomerase with telomere shelterin protein TPP1[J]. Nature，2022，604（7906）：578-583.
[36] PARSCH D，BRASSAT U，BRüMMENDORF T H，et al. Consequences of telomerase inhibition by BIBR1532 on proliferation and chemosensitivity of chondrosarcoma cell lines[J]. Cancer Invest，2008，26（6）：590-596.
[37] LIU W，YIN Y，WANG J，et al. Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC[J]. Oncotarget，2017，8（1）：179-190.

相似文献/References:

[1]刘新兰,李淑璟,张海霞.候选抑癌基因RASSF6在胃癌组织中的表达及其与临床病理特征的关系[J].天津医科大学学报,2015,21(04):287.
　LIU Xin -lan,LI Shu -jing,ZHANG Hai -xia.Expressions of RASSF6 in gastric cancer and its association with clinicopathologic feature[J].Journal of Tianjin Medical University,2015,21(06):287.
[2]李 静,孙保存,孙 冉,等.环氧合酶2通过上皮间质转换促进胃癌的侵袭与转移 [J].天津医科大学学报,2016,22(03):185.
　LI Jing,SUN Bao-cun,SUN Ran,et al.Cyclooxygenase-2 promotes gastric cancer invasion and metastasis by inducing epithelial to mesenchymal transition[J].Journal of Tianjin Medical University,2016,22(06):185.
[3]郭江涛综述,邓靖宇审校.胃癌淋巴结转移的分子标志物研究进展[J].天津医科大学学报,2017,23(01):85.
[4]赵忠治,王金淼,魏颖,等.术前外周血NLR与PLR对胃癌预后的评估价值[J].天津医科大学学报,2018,24(01):50.
　ZHAO Zhong-zhi,WANG Jin-miao,WEI Ying,et al.Evaluation value?of preoperative peripheral blood NLR and PLR? on prognosis of? gastric cancer[J].Journal of Tianjin Medical University,2018,24(06):50.
[5]张 悦,管叙文,王婧雅,等.miR-27a对胃癌细胞凋亡影响的体外研究[J].天津医科大学学报,2018,24(06):469.
　ZHANG Yue,GUAN Xu-wen,WANG Jing-ya,et al.Influence of miR-27a on apoptosis of gastric cancer cells in vitro[J].Journal of Tianjin Medical University,2018,24(06):469.
[6]白惠惠,邓靖宇,梁 寒.血清肿瘤标志物对胃癌淋巴结转移的诊断价值[J].天津医科大学学报,2019,25(03):241.
　BAI Hui-hui,DENG Jing-yu,LIANG Han.Prognostic value of serum tumor biomarkers for lymph node metastasis of gastric cancer[J].Journal of Tianjin Medical University,2019,25(06):241.
[7]张灿灿,谭志军.FMNL2在胃癌组织中的表达及其临床意义[J].天津医科大学学报,2020,26(02):149.
　ZHANG Can-can,TAN Zhi-jun.Expression and clinical significance of FMNL2 in gastric cancer[J].Journal of Tianjin Medical University,2020,26(06):149.
[8]赵珍珍 综述,邓靖宇 审校.蛋白质组学技术在胃癌研究中的应用[J].天津医科大学学报,2021,27(01):94.
[9]昕宇 综述,邓靖宇,梁寒 审校.主动脉旁淋巴结清扫术在进展期胃癌治疗中的研究进展[J].天津医科大学学报,2021,27(01):99.
[10]左兴盛,宋志玉,贾海盼,等.沉默circPVT1对5-氟尿嘧啶耐药胃癌细胞化疗增敏作用及机制研究[J].天津医科大学学报,2021,27(06):574.
　ZUO Xing-sheng,SONG Zhi-yu,JIA Hai-pan,et al.The sensitizing effect and mechanism of silencing of circPVT1 on 5-fluorouracil chemosensitivity in gastric cancer cells[J].Journal of Tianjin Medical University,2021,27(06):574.

备注/Memo

备注/Memo:

基金项目 天津市教委科研计划（2021ZD037）
作者简介 杨秋慧（1998-），女，硕士在读，研究方向：医学生物化学与分子生物学；通信作者：耿鑫，E-mail：gengx@tmu.edu.cn。

常用功能

更新日期/Last Update: 2023-12-01